WeightWatchers to enter prescription drug weight loss business
4.5 (630) · € 20.00 · En Stock
WeightWatchers shares soared Tuesday after the company said it was getting into the prescription drug weight loss business with the acquisition of Sequence.
Weight Watchers Enters Telehealth Space, Acquires Digital Company Sequence 03/10/2023
WeightWatchers bets on weight loss drugs with new program
Oprah, Ozempic and Apologies: WeightWatchers' New Formula - WSJ
WeightWatchers to buy Sequence, enter weight loss drug market
They're not practicing what they preached: WeightWatchers is shifting into weight loss drugs
The Disruptive Power of Weight Loss Drugs Is Being Felt Beyond Pharma - The New York Times
WeightWatchers: Telehealth Weight Loss Platforms & Ozempic
It's the Age of Ozempic. Do We Need WeightWatchers Anymore?
WeightWatchers' New CEO Pushes Points and Obesity Drugs - Bloomberg
